Theragenics lands new line of credit - Atlanta Business Chronicle:

ocybakenos.wordpress.com
The new credit agreement includesa $30 million revolvingb credit facility and a $10 milliom term loan. Maximum borrowings under the revolving credit facility can be increasedto $40 millioh under an accordion feature. The new credigt deal replaces and refinancesa $40 million revolving credit facility with Wachovia that was set to expire in October 2009. Borrowings of $32 milliob were outstanding under the old credit The financial covenants in the new creditg agreement are similar to the previouscredit agreement, except the requirementy to maintain at least $20 million in liquid assetas has been reduced to $10 The terms also require the maintenancre of certain minimum financial including a minimum fixed charge coverage ratil and a maximum debt to tangibled net worth.
“Obtaining our new creditg agreement is asignificant accomplishment,” said M. Christinde Jacobs, chairman and CEO of in a statement. “We believe that our abilituy to obtain this new credit agreement is a testament toour strategy, our focus on quality cash flows and the strengt h of our balance sheet. With our new credit agreemen tin place, we can continue to focus on organic growt h and building momentum towards 2010 in the short term, and continuwe our long-term strategy of diversification.” Buford, Ga.-based Theragenices (NYSE: TGX) is a surgical products and cancedr treatments company. Its f .